Current status of phase I clinical trials in Asia: an academic perspectives.
Explore this paper's citation graph
Summary
Improving collaboration and capacity building among the Asian countries is a solution that is proposed in order to increase the quality and quantity of phase I clinical trials in Asian countries.
- Type
- article
- Published
- 2012-01-01
- Cited by
- 11
- References
- 38
- OpenAlex
- https://openalex.org/W116301993
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:44323490
Keywords
Clinical trial, Medicine, Alternative medicine, Clinical research, Phase (matter)
References
- Advances in pharmacogenomics and individualized drug therapy: exciting challenges that lie ahead.
- The quality of conduct in Japanese clinical trials: deficiencies found in GCP inspections.
- Clinical trials for drug registrations in Asian-Pacific countries: proposal for a new paradigm from a statistical perspective.
- Ethical and scientific implications of the globalization of clinical research.
- Implementation of good clinical practice guidelines in vaccine trials in developing countries.
- Clinical trials in India.
- Racial disparities in clinical trials.
- Exploiting a research underclass in phase 1 clinical trials.
- Current status of quality in Japanese clinical trials.
- Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.
- Trends in the globalization of clinical trials
- Representation of South Asian people in randomised clinical trials: analysis of trials' data
- Fundamentals of Clinical Trials
- Changing Patterns of Dengue Epidemiology and Implications for Clinical Management and Vaccines
- Research involving human subjects in developing countries.
- Ethical issues in the design and conduct of clinical trials in developing countries.
- A new colonialism?--Conducting clinical trials in India.
- South Asian participation in clinical trials: the views of lay people and health professionals.
- Antiretroviral therapy in a thousand patients with AIDS in Haiti.
- Opportunities and strategies for introducing pharmacogenetics into early drug development.
Cited by
- The need for multicentre cardiovascular clinical trials in Asia
- Managing clinical trials in Asia: Issues, threats, opportunities and approaches
- Evolution of the clinical trial landscape in Asia Pacific
- Impact, challenges, and future projections of vaccine trials in Africa.
- Vaccine trials in Africa: Impact and challenges
- Health research capacity development in low and middle income countries: reality or rhetoric? A systematic meta-narrative review of the qualitative literature
- Addressing the unmet need in respiratory viruses: an interdisciplinary analysis of product development pipeline in Asia
- Characteristics of Asian 4 countries on cancer clinical trials registered in the International Clinical Trials Registry Platform between 2005 and 2018.
- The Characteristics of Clinical Studies Submitted to the Saudi Food and Drug Authority from 2009 until 2020
- A global perspective: characteristics of infertility‐related randomized clinical trials
- Dementia Clinical Research in India
Related papers
- Regulation and status of herbal medicine clinical trials in Korea: a narrative review
- Conducting clinical trials in Singapore.
- Construction of ethics in clinical research - Clinical trials registration
- Attitudes towards and participation in randomised clinical trials in oncology: a review of the literature.
- Acute kidney injury biomarkers and endpoints for clinical trials.
- Participants’ perception of pharmaceutical clinical research: a cross-sectional controlled study
- The UK clinical research network - has it been a success for dermatology clinical trials?
- Improve the ethical review of clinical trials on traditional medicine
- Clinical Studies with Traditional Chinese Medicine in the Past Decade and Future Research and Development
- Regulation of research: is it a drug trial or a supplement trial?